Therapeutic potential for leukocyte elastase in chronic pain states harboring a neuropathic component-Reference-Cited by-同舟云学术

Therapeutic potential for leukocyte elastase in chronic pain states harboring a neuropathic component

Published:2017-08-19 Issue:11 Volume:158 Page:2243-2258
ISSN:0304-3959
Container-title:Pain
language:en
Short-container-title:PAIN

Author:

Bali Kiran Kumar,Kuner Rohini

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Anesthesiology and Pain Medicine,Clinical Neurology,Neurology

Reference50 articles.

1. Reevaluation of the efficacy and safety of the neutrophil elastase inhibitor, Sivelestat, for the treatment of acute lung injury associated with systemic inflammatory response syndrome; a phase IV study;Aikawa;Pulm Pharmacol Ther,2011

2. Clinical utility of the neutrophil elastase inhibitor sivelestat for the treatment of acute respiratory distress syndrome;Aikawa;Ther Clin Risk Manag,2014

3. Dosing time-dependent changes in the analgesic effect of pregabalin on diabetic neuropathy in mice;Akamine;J Pharmacol Exp Ther,2015

4. The costs and consequences of adequately managed chronic non-cancer pain and chronic neuropathic pain;Andrew;Pain Pract,2014

5. Transcriptional mechanisms underlying sensitization of peripheral sensory neurons by granulocyte-/granulocyte-macrophage colony stimulating factors;Bali;Mol Pain,2013

Cited by 29 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Granzyme B in aging and age-related pathologies;Trends in Molecular Medicine;2024-08

2. Drug Repurposing Patent Applications January–March 2024;ASSAY and Drug Development Technologies;2024-07-01

3. Steroid inhibited Serpina3n expression which was positively correlated with the degrees of spinal cord injury;Heliyon;2024-03

4. The role of neuroinflammation in the transition of acute to chronic pain and the opioid-induced hyperalgesia and tolerance;Frontiers in Pharmacology;2023-12-15

5. Immunotherapies in chronic pain through modulation of neuroimmune interactions;Pharmacology & Therapeutics;2023-08